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Abstract
MiRNAs can regulate gene expression through versatile mechanisms that result in increased or decreased expression of the
targeted mRNA and it could effect the expression of thousands of protein in a particular cell. An increasing body of evidence
suggest that miRNAs action can be modulated by proteins that bind to the same 39UTRs that are targeted by miRNAs,
suggesting that other factors apart from miRNAs and their target sites determine miRNA-modulation of gene expression.
We applied an affinity purification protocol using biotinylated let-7 miRNA inhibitor to isolate proteins that are involved in
let-7 mediated gene regulation that resulted in an affinity purification of Polypyrimidine Tract Binding protein (PTB). Here we
show that PTB interacts with miRNAs and human Argonaute 2 (hAgo2) through RNA as well as identified potential
mammalian cellular targets that are co-regulated by PTB and hAgo2. In addition, using genetic approach, we have
demonstrated that PTB genetically interacts with Caenorhabditis elegans let-7 indicating a conserved role for PTB in miRNA-
mediated gene regulation.
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Introduction
MicroRNAs (miRNAs) are conserved key regulators of gene
expression. They mainly repress protein translation via seemingly
distinct mechanisms (reviewed in: [1]) however; recently they were
also shown to be involved in enhancing translation at specific
cellular environment [2]. miRNAs are essential for proper
development in diverse organisms, they are involved in many
disease including cancer. Furthermore, in mammals miRNAs alter
the expression of thousands of proteins suggesting that they are
also responsible for regulating the protein homeostasis in cells by
fine-tuning the proteome [3,4]. miRNAs are incorporated into the
RNA induced silencing complex (RISC), in which the core protein
an Argonaute family member (reviewed in: [5]). These complexes
pair with their targets through the seed sequences that span from
2
nd to the 8
th nucleotide of the 59 end of a miRNA. There are
increasing amount of evidence that other RNA binding proteins
are also involved in modulating miRNA-mediated gene expression
at the effector step. HuR, an AU-rich element (ARE) binding
protein, was demonstrated to relieve the miR-122 mediated CAT-
1 repression in human hepatocarcinoma cells upon amino acid
starvation [6]. Another RNA binding protein Dnd1 was shown to
protect miR-430 targeted mRNAs in zebrafish primordial cells
and miR-372 targeted mRNAs in human cells derived from germ
line through binding to U-rich regions (URR) located in the
miRNA targeted mRNA regions [7]. CRD-BP (IMP-1) attenuates
miR-183-mediated gene silencing by preventing the association of
Ago2 complexes with the regulated 39 UTR [8]. Furthermore, the
affinity purification with tagged human Ago2 resulted in the co-
purification of a range of RNA binding proteins that have
functions in diverse step of RNA biogenesis, transport and RNA
translation. Indeed, UPF1 and RBM4 (both associated with hAgo2
and hAgo1) have already been demonstrated to be required for
miRNA-mediated gene silencing [9,10]. Some of these co-factors
identified by proteomics could also modulate miRNA-mediated
gene expression in a target or miRNA specific manners since RNA
was shown to mediate many of these interactions [10].
Polypyrimidine Track Binding protein (PTB), or hnRNP I, is a
shuttling RNA binding protein that recognizes short pyrimidine
rich sequences and it is involved in the regulation of a wide variety
of RNA-dependent biological processes (reviewed in [11]). PTB is
a negative and positive regulator of alternative splicing and it
regulates its own splicing [12,13,14,15,16,17]. PTB could also bind
to the 39UTR of mRNAs and this interaction was shown to be
important to regulate mRNA transport and the stability of certain
mRNAs [18,19,20,21,22]. PTB is a key factor in Internal
Ribosomal Entry Site (IRES) mediated translation initiation of
viral (reviewed in [23]) and cellular mRNAs via its association with
the 59UTRs of these mRNAs [24,25,26]. PTB has four RNA
recognition motif (RRM) domains and all are capable of binding
RNAs [27]. An important structural feature of its interaction with
RNA is that RRMs 3 and 4 form a stably packed ‘‘back-to-back’’
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RNA between the two pyrimidine motifs recognized by RRMs 3
and 4 [28] [29]. PTB could execute some of its diverse functions
by acting as a RNA chaperone and restructuring the RNA so as to
either mask, or promote the accessibility of, binding sites for other
effector proteins or miRNAs [30]. Interestingly, expression of both
PTB and its paralogue nPTB are regulated by miRNAs during
neuronal and muscle differentiation, and PTB also regulates
expression of its paralogues via splicing [31,32,33]. Moreover,
PTB can be affinity purified with the conserved loop sequence of
the hsa-miRNA-101-1, suggesting a potential role in the regulation
of the processing of this miRNA family [34].
Here we have shown that PTB is in complex with human Ago2
and miRNAs. We have also identified potential mRNAs that are
co-regulated by PTB and Ago2 post-transcriptionally in human
cells. Furthermore, a genetic interaction observed between C.
elegans PTB and let-7 miRNA supports a conserved function of
PTB in modulating miRNA-mediated gene regulation.
Results
Affinity purification of PTB using biotinylated 29-O-
Methyl let-7 inhibitor
Inhibitors of miRNAs are widely used in vitro and in vivo in
diverse cells and organisms for investigating miRNA functions and
characterizing miRNA-target interactions [35,36,37]. These
efficient and specific inhibitors are usually modified RNase
resistant oligonucleotides with a perfect complementary to their
target miRNAs. A 29-O-Methyl containing oligonucleotide inhib-
itor that interferes with let-7 function in human cells and C. elegans
has already been reported (Fig. 1A) [36]. In addition, a biotin
tagged version of this oligo pulls down constituents of miRNA
complexes [36,38]. We asked if we could use this approach to
purify additional proteins associated with the let-7 programmed
miRNA induced silencing complex (miRISC) in human cells. First,
we tested if we could detect let-7 and human Ago2, the
components of the let-7 programmed minimal RISC, in the
bound fraction purified with the biotinylated let-7 complementary
oligo from HeLa cell lysates. The affinity purification showed that
both Ago2 and let-7 were bound to the let-7 specific oligo but they
were not detectable in the bound fraction of the affinity
purification carried out with a non-specific 29-O-Methyl oligo
(Fig. 1B). Next, we carried out scaled-up affinity purifications to
identify proteins that bound specifically along with let-7 and the let-
7 associated RNPs. We found several proteins that co-purified with
the let-7 complementary oligo, but the only protein that we
identified in at least two independent affinity purifications was
PTB (Fig. 1C, the two panels show the result of the two
independent affinity purifications).
PTB binding to the let-7 complementary oligo is sensitive
to mutations in the let-7 seed complementary sequence
Since PTB is an abundant RNA binding protein, we asked
whether binding of the protein to the column depends on
characteristics of the miRNA-target interactions or if it is a non-
specific interaction with the 29-O-methyl RNA column. MiRNAs
bind their target through the seed sequence; we therefore mutated
two nucleotides in the let-7 oligo that pair with the seed sequence
of members of the let-7 miRNA family (Fig. 1A). We first tested this
oligo in miRNA inhibitory study in human cells to see if we were
able to abrogate its influence of miRNA-mediated gene regulation.
We co-transfected the control, the let-7 complementary, and the
let-7 seed mismatched oligos into HeLa cells together with a
luciferase reporter plasmid that carried a portion of the 39UTR of
the human HMGA2, which contains four bona fide let-7 target
sites [39,40]. As expected, the let-7 complementary oligo enhanced
the expression of the reporter plasmid significantly by inhibiting
the miRNA function (Fig. 2A). On the other hand, the let-7
mismatched oligo did not show any significant effect on the
expression of the let-7 reporter suggesting that the mutated oligo
no longer interferes with miRNA action (Fig. 2A). Next we used
the seed mismatched oligo in affinity purification experiments to
see how its affinity to the component of the let-7 programmed
miRISC and PTB is affected. Quantification of bound let-7
showed that the seed mismatched oligo bound only half the
amount of let-7 that was affinity purified with the let-7
complementary oligo (Fig. 2B). In addition, the introduced seed
mismatches significantly reduced the oligo affinity to Ago2 and
PTB (Fig. 2C and D). We noticed that the oligo we are using for
affinity purification contains a canonical PTB binding motif:
UCUUC (Fig. 1A). To determine whether the interaction between
PTB and the oligo is mediated by this motif, we generated a new
oligo with two mutations in the putative PTB binding site (Fig. 1A:
PTB(-) oligo). Affinity purification with this oligo showed similar
levels of bound Ago2, PTB and let-7, indicating that our
purification was indeed dependent upon the let-7 binding and
thus specific (Fig. 2C).
PTB interacts with the miRNA programmed RISCs in an
RNA dependent manner
To confirm the association between PTB and the let-7 pro-
grammed RISC, we first carried out immunoprecipitation
experiments with antibodies raised against PTB. We showed that
PTB imunoprecipitates with Ago2 (Fig. 3A upper panel) and the
mature let-7 miRNA (Fig. 3A lower panel). In order to test if this
interaction is specific, we repeated this experiment using different
lysis protocols (Figure S1A and B) and antibodies that recognizes
different epitopes of PTB (Figure S1C). In all cases, we could
detect Ago2 and let-7 specifically associated with the PTB bound
fractions. Next, we transfected HeLa cells with a GFP::PTB fusion
plasmid in parallel with plasmid only expressing GFP and we
carried out immunoprecipitation with a GFP specific antibody.
We found that Ago2 and let-7 co-immunoprecipitate with the
GFP::PTB but not with GFP alone (Fig. 3B). Finally, we generated
U2OS cells constitutively expressing GFP::PTB and repeated the
immunoprecipitation . This experiment again showed that let-7
specifically associated with PTB (Fig. 3C). Finally, we carried out
co-fractionation experiment and observed that a substantial
fraction of let-7 co-fractionates with PTB (Figure S2).
Next we asked whether other miRNAs are associated with PTB
or its association is specific to let-7. When we re-hybridized the
RNAs derived form PTB IPs with a probe detecting miR-21, we
observed its presence in the PTB containing bound fractions
(Figure S3A and B). This data suggest that PTB interacts with
diverse miRISCs and it may have a more general role in miRNA-
mediated gene regulation.
Next we tested whether PTB binds to RISC solely via protein-
protein interaction or if its binding is mediated by RNA. When we
RNAse treated the bound fraction of the immunoprecipitated PTB
we observed that the majority of Ago2 was released from the bead
suggesting that PTB is primarily associated with miRNA
complexes via RNAs (Figure 3D).
Knocking down PTB in HeLa cells results in the upregulation of
nPTB, the neuron specific homologue of PTB, that has similar
function in the regulation of splicing in HeLa cells [32]. Therefore,
we tested if the depletion of PTB could induce nPTB expression
and whether nPTB could bind to miRNA complexes. As
previously observed, when PTB expression was inhibited with
PTB Is Associated with miRISCs
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[31,32,33] (Fig. 4A). We also showed that the XR tagged nPTB
co-immunoprecipitates with let-7 (Fig. 4B). This data suggests that
the PTB paralogues might have redundant functions in miRNA-
mediated gene regulation.
PTB alters Argonaute 2 association of human mRNAs
After establishing the connection between PTB and the miRNA
loaded RISC, we went to look for mRNAs that are regulated by
miRNAs to determine whether PTB could modulate this
interaction. We hypothesized that if PTB and miRNAs are
involved in the regulation of mRNAs then knock-down of PTB
should affect the association of the miRNA-targeted mRNAs with
miRISC. Spellman and colleagues reported a 2D DiGE
proteomics analysis that identified proteomic changes in response
to PTB knock-down in HeLa cells [32]. While many of the
observed changes in protein expression were explained by PTB-
dependent alternative splicing, some of the up and down-regulated
Figure 1. Affinity purification of let-7 associated complexes. (A) Biotinylated 2-O-methylated oligos used in this study. Sequences highlighted
with red are complementary to let-7a. Blue nucleotides indicate changes generated from the original let-7 oligo. (B) Northern hybridization (top
panel) and Western blot (bottom panel) show that let-7 oligo specifically purifies let-7 miRNA and hAgo2 protein. sup.: supernatant; c and cont.:
control oligo. (C) Proteins co-purify with let-7 oligo. Right and left panels show the results of the independent affinity purifications. Proteins that are
specifically pulled down with the let-7 oligo are labeled next to the stained gels.
doi:10.1371/journal.pone.0033144.g001
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these proteins are potential candidates for co-regulation by PTB
and miRNAs.
We therefore knocked down PTB and nPTB expression in Hela
cells in triplicates and immunoprecipitated Ago2 from the cells
transfected with the control and PTB/nPTB siRNAs (Figure 5A).
We next purified RNAs from the Ago2 immunoprecipitates and
subjected them to q-PCR using primers that specifically amplify
ten candidate mRNAs chosen from the result of the 2D DiGE
proteomics. Then, we quantified the changes in the relative
abundance (normalized with the level of GAPDH mRNA) of the
selected mRNAs in the Ago2 IPs derived from the PTB/nPTB
knock down samples by comparing them to the Ago2 IPs were
carried out from the control siRNA transfected cells. We also
measured the level of the selected mRNAs in total RNAs isolated
from the control and PTB/nPTB knock cells. We observed that
knocking down PTB/nPTB does not have significant affect on the
steady state mRNA levels for most of the selected putative targets
(Figure 5 B–F). In the case of five putative targets, we found
significant differences in the change of the levels of mRNAs
associated with Ago2 after PTB/nPTB knock down suggesting
that these mRNAs are co-regulated by PTB and miRNAs post-
transcriptionally. In four cases (ECH1, CPS1, P4HB, EFHD2) the
relative mRNA levels were decreased in the Ago2 IP after PTB/
nPTB knock down, indicating that PTB promotes miRNA binding
(Figure 5B–E). These cases are consistent with the preceding
observations of an association between PTB and Ago2. In
contrast, PTB depletion resulted in an increase of RAD23B
mRNA in the Ago2 immunoprecipitates, indicating that in this
case PTB antagonizes the miRNA-mediated gene regulation of
RAD23B (Figure 5F). The majority of these five mRNAs have
conserved miRNA target sites predicted by Targetscan (http://
www.targetscan.org) and/or PicTar (http://pictar.mdc-berlin.de)
corresponding to miRNAs are expressed in HeLa cells [41]. Also,
Rad23B was shown to be targeted by miRNAs in hypoxia [42].
The only exception is ECH1 that only contains non-conserved
predicted miRNA target sites. Also, 4 out of 5 potential PTB/
miRNA targets (CPS1, EFHD2, P4HB and RAD23) were
identified to bind to PTB using PTB iCLIP experiments (J. Ule
personal communication) [17].
PTB modulates let-7 mediated gene silencing in C.
elegans
In order to test if the functional interaction between PTB and
miRNAs are conserved, we decided to test this interaction in
animals using the nematode Caenorhabditis elegans. Since let-7 loss-of-
function is lethal [43], we used a C. elegans strain that carries a
thermosensitive (ts) allele of the let-7 gene ((let-7(n2853)); [43]. We
can therefore test if the C. elegans ortholog of the human PTB gene
Figure 2. PTB association with the let-7 bead depends of the let-
7 seed complementary sequences. (A) let-7 seed mutant oligo
could not inhibit let-7 mediated gene repression. Renilla luciferase
expressing plasmid containing a part of the 39 UTR of human HMGA2
that carries four let-7 target sites were transfected into HeLa cells
together with Firefly expressing plasmid, as internal control, and the
indicated 29-O-methyl oligos. The graph shows the result of the dual-
luciferase assay normalized to the control oligo. The error bars
represent the standard error of three experiments. (B) let-7, hAgo2
and PTB are sensitive to the presence of the seed sequence of the let-7
oligo. The quantity of let-7 miRNA associated with the indicated oligos
was quantified using Northern hybridization and normalized to the
amount of miRNA pulled down with the wild-type let-7 oligo. The
presences of hAgo2 and PTB on the indicated beads were monitored by
Western hybridization. (C) PTB association with the let-7 column does
not depend on the presence of the canonical PTB site in the oligo.
Affinity purifications were carried out with the indicated oligos and the
association of miRNAs, hAgo2 and PTB with these oligos was monitored
by Northern hybridization and Western blotting. sup.: supernatant.
doi:10.1371/journal.pone.0033144.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33144Figure 3. PTB is associated with hAgo2 and let-7 miRNA. Endogenous PTB in Hela cells (A), PTB fused with GFP in HeLa cells (B) and stably
expressed GFP::PTB in U2OS cells (C) co-purify with endogenous hAgo2 and let-7. Immunoprecipitations (IP) were carried out with the indicated
antibodies. The bound fractions were assayed for hAgo2 and PTB with western blotting (top panels) and for let-7 with Northern hybridization (bottom
panels). (D) PTB association with Ago2 is mediated by RNA. IPs were carried out with antibodies against GFP and PTB. The parts of the bound fraction
were subjected to RNase treatment and the supernatants of the RNAse treated beads and the remaining bound fractions were assayed for hAgo2 and
PTB by Western blotting.
doi:10.1371/journal.pone.0033144.g003
PTB Is Associated with miRISCs
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33144called ptb-1 contributes to let-7-mediated gene regulation in
animals. While ptb-1(gk113) animals has no obvious phenotype,
the loss of ptb-1 in let-7ts animals enhanced the observed phenotype
(the double mutant population has twice as much sterile animals
than the let-7ts animals: Figure 6A). Since we did not observe
change in the steady state level of let-7 in the double mutant
(Figure 6B), we concluded that PTB is likely required for miRNA-
mediated gene silencing at the effector step.
Taken together, our data suggest that like observed in humans,
C. elegans PTB is working in collaboration with let-7 miRNA to
regulate let-7-specific gene.
Discussion
We have affinity purified PTB with biotinylated miRNA
complementary oligonucleotides and showed that PTB/nPTB
associate with the miRISC in an RNA dependent manner. This
observation suggests that the interruption of the miRNA and the
target mRNA with complementary miRNA oligonucleotides does
not necessarily results in the full dissociation of the miRISC and
the targeted RNA.. It is plausible that the dissociated miRISC is
still associated with the targeted mRNA via its binding to the rest
of the regulatory complex and/or nearby co-regulatory miRISC
and PTB/nPTB also bind to these RNAs.
There is increasing amount of evidence that RNA binding
proteins that bind to the 39UTRs of mRNAs have important roles
in regulating miRNA-mediated gene expression. HuR has been
shown to relieve the attenuation of gene expression mediated by a
specific miRNA in specific cells as a consequence of amino acid
starvation [6]. Dnd1, a developmentally regulated RNA binding
protein modulates functions of several miRNAs in vertebrates by
binding to U-rich sequences of the 39UTRs and inhibiting the
accessibility of miRNA target sites of a subset of mRNAs [7]. It
was also demonstrated that IMP-1 binds to the 39UTR of the
Figure 4. nPTB could also be associated with miRISC. (A) The knock down of PTB results in the increase of nPTB expression in HeLa cells. PTB
was knock down with specific siRNA and PTB and nPTB levels were monitored with Western blotting. Tubulin was used as a loading control. *: non-
specific hybridization visualized by he nPTB abtibody. (B) nPTB is associated with miRNA. XR tagged nPTB was overexpressed and IP was carried out
with antibody recognizing XR. The efficiency of the IP was checked with Western blotting using XR and nPTB antibodies. RNA was purified from the
immunoprecipitates and assayed for the presence of let-7 using Northern blotting. c: empty bead.
doi:10.1371/journal.pone.0033144.g004
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The affinity purification with human recombinant Argonaute
proteins revealed that many RNA binding proteins with functions
in diverse steps of mRNA maturation, transport, mRNA
stabilization and translation co-purify with hAgo1 and hAgo2.
Among them, RBM4 and UPF1 were shown to be required for
miRNA-mediated gene regulation [9] [10] The depletion of these
two proteins resulted in similar effect that we observed in PTB/
nPTB knock down in Hela cells in the majority of the cases. What
could be the mechanism by which PTB is involved in miRNA-
mediated gene regulation?
Apart from its function as a regulator in splicing PTB has been
demonstrated to participate in a wide range of cytoplasmic event
by binding to mRNAs (recently reviewed in [11]). PTB is a well-
characterized IRES-trans-acting-factor (ITAF) that involved in
regulating the translation of viral and cellular IRES containing
RNAs by binding to the IRES elements in their 59UTR
[24,25,26]. PTB also can regulate gene expression by binding to
elements in the 39UTR. For instance, PTB has been demonstrated
to stabilize certain mRNAs such as insulin, VEGF, iNOS, CD154,
PGK2, also via binding to the 39UTR of these messages
[18,19,20,21,22]. However, it is very likely that PTB has
additional yet uncharacterized functions in the cytoplasm because
immunoprecipitation of the cytoplasmic PTB fraction followed by
microarray profiling in HeLa cells showed that more then 1600
mRNAs are enriched in the PTB purified complex suggesting a
more general role for PTB in the cytoplasm [44]. Interestingly, this
study also revealed that the PTB associated transcriptome consist
of mRNAs that have significantly longer 39UTRs which is also a
characteristic of miRNA regulated transcripts [45]. In addition,
PTB sites have been shown to be enriched in the 39 UTRs and the
coding regions that are also frequently targeted by miRNAs
[44,45]. Moreover, many of the changes in protein expression that
occur in HeLa cells upon knock-down of PTB and nPTB cannot
be explained by changes in alternative splicing of their mRNAs.
[32].
PTB binds to short stretches of pyrimidine-rich sequences with
its four RRM domains, and this binding could either directly
obstruct binding of other proteins or indirectly facilitate or prevent
the binding of other proteins to the RNA by modulating the RNA
structure. This restructuring capability of PTB was suggested to be
crucial in IRES initiated translation in which PTB creates loops
that is necessary to the association of the 40S ribosome. Similar
conformational changes, mediated by PTB binding, were
implicated in preventing the binding of splicing factors or proteins
that destabilize mRNAs. We hypothesize that PTB act as an
auxiliary factor that facilitates miRNA-mediated gene regulation
by restructuring mRNAs to provide optimal target accessibility for
miRNAs. PTB co-immunoprecipitation with miRISCs is mediated
by RNA (Fig. 3D) suggesting that PTB could bind first to the
miRNA targeted mRNA, thereby promoting an accessible target
site conformation for miRISC binding. A similar mechanism has
been proposed in the case of hUPF1 since its helicase domain was
shown to be required for miRNA-mediated gene regulation [9].
The existence of PTB-like factors has already been envisaged
since in some cases the target recognition of miRNAs do not fully
Figure 5. PTB alters Ago2 association of mRNAs in HeLa cells. (A) PTB and nPTB was simultaneously knocked down in triplicates in HeLa cells
and Ago2 was immunoprecipitated from control and PTB/nPTB siRNA transfected cells. PTB, nPTB, Ago2 expression was followed by Western
hybridization. Tubulin was used as loading control. *: non-specific band detected with the nPTB antibody. (B–F) q-PCR analysis of mRNAs which
association with Ago2 is modulated by PTB. RNAs were isolated from control and PTB/nPTB siRNA transfected cells and from Ago2 IPs obtained from
the same cells. RNAs were quantified and normalized with GAPDH RNA. The data show the relative abundance of the normalized RNAs compared to
the control siRNA transfected cells and the Ago2 IP from the same cells. Error bars represent the standard deviation of three independent
experiments (A). *: p,0.05, **: p,0.001.
doi:10.1371/journal.pone.0033144.g005
Figure 6. PTB and let-7 miRNA contribute together to regulate
gene expression in C. elegans. (A) Synchronized L1 animals were
placed at semi-permissive temperature (20uC) and adult animals were
scored after seventieth-two hours. The animal sterility observed in the
population is caused by either a vulval bursting at the L4-adult
transition or by a severe gonadal defect. Error bars represent the 95%
confidence interval from independent experiments (n) where between
20 and 40 animals have been scored. ***: p,0.0001 (B) let-7 level
remained unchanged in the let-7ts/ptb-1 animals. RNAs were purified
from the indicated genotypes and probed for let-7 and U6 RNAs. The
amount of RNA was used for Northern blotting is indicated on the top
of the panel and the U6/let-7 ratios are presented at the bottom of the
panel.
doi:10.1371/journal.pone.0033144.g006
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computational approaches that predict miRNA target sites
[46,47,48]. Furthermore, detailed analysis of the interaction
between C. elegans miRNA lys-6 and its mRNA target cog-1
revealed the importance of the general context of the 39UTR in
miRNA-mediated gene regulation and suggested that miRNA
target interactions should be investigated case by case [47]. In
vitro studies however: concluded that siRNA loaded RISCs do not
need auxiliary factors for target scanning and cleavage if the
thermodynamic properties of the siRNA target sites are favorable
[49]. Using short target sequences the authors showed that siRNA
loaded RISCs could efficiently cleave the target RNA if the target
site is less structured. However, miRNA targeted mRNAs
characteristically have long 39UTRs and in this context it is very
likely that RNA binding proteins, like PTB, are required to
provide such an open structure for efficient targeting [45]. Our
genetic experiments in C. elegans suggest that at normal miRNA
level PTB may be dispensable but when the miRNA level is
limited, PTB is required for efficient miRNA-mediated gene
regulation probably by providing a structure that is more
accessible for targeting.
Materials and Methods
Oligonucleotides, siRNAs
Biotinylated 29-O-Methyl oligos were purchased from Dharmacon.
Let-7 complementary oligo:
59-biotin-UCUUCACUAUACAACCUACUACCUCAACCUU-
39,
let-7 seed mismatched oligo:
59-biotin-UCUUCACUAUACAACCUACUACGAGAACCUU-
39
PTB(-) oligo:
59-biotin-UGAUCACUAUACAACCUACUACCUCAACCUU-
39
control oligo:
59-biotin–CAUCACGUACGCGGAAUACUUCGAAAUGUCC
-39
siRNAs to knock down PTB and nPTB expression were purchased
from Dharmacon (On target plus, catalog numbers J-003528-06, 07,
08 and 09 and J-021323-09, 10, 11, and 12 respectively) and were used
as an equimolar mixture. For simultaneous PTB and nPTB knock
down the equimolar mixtures of PTB and nPTB siRNAs were used
in a 2:1 ratio. As a negative control unrelated siRNA was used: 59-
AGGUAGUGUAAUCGCCUUGTT-39,5 9-CAAGGCGAUUA-
CACUACCUTT-39.
DNA oligo (Sigma) to detect C. elegans U6 RNA: 59-AATTT-
GCGTGTCATCCTTGCGCA-39.
RNA oligonucleotides to detect human and C. elegans let-7 in
Nortern hybridization: 59-UAUACAACCUACUACCUCAUU-
39, to detect human miR-21: 59-UCAACAUCAGUCUGAUAA-
GCUA-39 synthetic let-7a:5 9-UGAGGUAGUAGGUUGUAU-
AGU-39 and RNA to detect tRNA-Ile: 59-UGGUGGCCCGUA-
CGGGGAUCGA-39 were purchased from Dharmacon and
MWG. Decade 10 bp RNA marker (Ambion) was used as addi-
tional size marker.
Antibodies and Western blotting
Primary antibodies were used in this study to detect human
PTB: mouse monoclonal Ab (SH54) NA63 (Calbiochem), goat
polyclonal Ab sc-16547 (SantaCruz), mouse mAb BB7 (gift from
Chris W. Smith, Cambridge, [50]). For detecting human Ago2: rat
monoclonal 11A9 (gift from Gunter Meister, [51]), mouse
monoclonal Ab 4F9, sc-53521 (SantaCruz). To detect GFP:
mouse monoclonal Ab (Roche). To detect human tubulin: mouse
monoclonal Ab DM1A (Sigma). Secondary antibodies were
peroxidase conjugated (Jackson Immuno Research). Western
blotting was performed by following standard protocols, using
gel cassettes (Invitrogen) or the NuPage system (Invitrogen).
Proteins were electroblotted and detected either with Thermo
Scientific Supersignal West Chemoluminescent substrate or
with Millipore Immobilon Western chemonluminescent HRP
substrate.
Plasmids
The following plasmids were used in this study: PTB::GFP,
XR::nPTB (gifts from Chris Smith), pEGFP (Clontech). Firefly
luciferase: PGL2. Renilla luciferase reporter constructs: pRL-TK
H2-H5: Renilla luciferase that containing four let-7 target sites in
the 39UTR in the context of the part of HMGA2 39UTR , pRL-
TK DH2-DH5: same as H2-H5 only the seed sequences
complementary sites of the let-7 were mutagenized at second
and third nucleotides.
Cell culture, transfection and cell lysis
Stable GFP and GFP::PTB expressing cell lines were generated
by transfection of U2OS (gift from S. Rocha WT centre for GRE,
Dundee University) cells with Effectene (Qiagen) and selection
using 400 mg/ml of G418. Single colonies were picked after
limited trypsinisation and checked for expression by immunoflu-
orescence and Western blotting.
Transfections were performed with Effectene (Qiagen), Lipo-
fectamine 2000 (Invitrogen) and oligofectamine (Invitrogen) and
Lipofectamine RNAiMAx (Invitrogen) according to the manufac-
turers instructions.
The following cell lysis protocols were used in this study: NP40:
50 mM Tris pH 7.5, 150 mM NaCl, 1% NP40, RIPA: 50 mM
Tris pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycho-
late, 0.1% SDS, Polysome buffer: 0.5% NP40 alternative,
130 mM KCl, 10 mM MgCl2, 2.5 mM DTT. Mammalian Cell
lysis buffer (MCLB): 50 mM Tris pH 7.4, 150 mM NaCl, 1%
Triton X100, 1.25 ml/ml beta mercaptoethanol and 0.9 g/ml
sucrose All buffers were supplemented with Complete protease
inhibitor (Roche) and RNasin (Promega).
Affinity purifications with biotinylated 29-O-Methyl
oligonucleotides
Ten to fifteen 10 cm dishes of HeLa cells (gift from A. I.
Lamond laboratory, WT Centre for GRE, Dundee University),
(,80–90% confluent) were lysed in NP40 lysis buffer. 25 ml
streptavidin magnetic beads (Dynal, Invitrogen) were equili-
brated with 26 Binding buffer (10 mM Tris, pH 7.5, 1 mM
EDTA, 2.0 M NaCl) by washing the beads with three times.
Beads were resuspended in 100 ml1 6 Binding buffer and
100 pMol biotinylated 29-O-Methyl oligonucleotides were add-
ed and incubated for two hours in the cold room with gentle
agitation. After incubation the beads were washed three times
with 16 Binding buffer and two times with lysis buffer. 500–
1000 ml lysate were added and incubated on 37Cu for one hour.
The beads were washed three times with lysis buffer and
resuspended in 50 ml lysis buffer. RNA was isolated with 26PK
b u f f e r( 2 0 0m MT r i sp H7 . 5 ,2 5m ME D T A ,3 0 0m MN a C l ,
2% SDS, 2 mg/mlp r o t e i n a s eK )f o l l o w e db yp h e n o le x t r a c t i o n
and ethanol preciptitation and monitored with Northern
hybridization. For protein assay the washed beads were boiled
with the SDS loading dye and the eluate was subjected to
Western blotting.
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Antibodies were bound to Dynabeads protein G (Dynal,
Invitrogen) and washed with lysis buffer. Cells were lysed with
RIPA or MCLB buffers, incubated overnight with the bound
antibodies and were washed with lysis buffers. RNA was isolated
with 26 PK and proteins were eluted by boiling the bound
fraction in SDS loading buffer and analyzed by Western blotting.
Gel filtration
Gel filtration was performed on an Akta Explorer machine
using a Sepachryl-S300 column (Amersham) in a 4uC cabinet.
Cells were lysed in: 50 mM Tris pH 7.9, 12.5 mM MgCl2, 10%
glycerol, 0.015% NP40 and 150 mM KCl. Fractions were
collected and RNA and protein were isolated with 26PK buffer
and monitored with Northern or Western blotting respectively.
Low molecular weight marker (Amersham) was used to calibrate
the elution profile. The quantity of let-7 of the fractions was
determined using 1 and 10 femtomole let-7 standards run
alongside the fractions on Northern blots.
Northern hybridizations
Standard Northern blotting for the detection of small RNAs
were performed as described [52]. BasIP-MS-2040 imaging plates
(Fujifilm) were scanned with FLA-5100 (Fuji) and the data were
quantified using ImageGauge v4.21 software.
C. elegans protocol
The ptb-1 (gk113) and let-7ts (n2853) strains were obtained from
the C. elegans Gene Knockout Consortium. C. elegans experiments
were performed at 20uC during the indicate time. For survival
analysis, a population of let-7ts (n2853); ptb-1 (gk113), let-7ts (n2853)
and wild-type N2 animals were synchronized as L1 larvae, grow
on plates and scored for % of survival adult animals with embryos
after 72 hours at semi-permissive temperature (20uC).
Supporting Information
Figure S1 PTB co-purifies with the let-7 loaded RISC.
PTB association with the let-7 loaded human RISC is maintained
by using different lysis protocols (A) and; using different antibodies
of hAgo2 and PTB (B). The bound fractions of the PTB
immunoprecipitates were assayed for hAgo2 and PTB with
Western blotting (top panels) and for let-7 with Northern
hybridization (bottom panels). (C) GFP tagged PTB also
immunoprecipitates endogenous hAgo2 (top panel) and let-7
miRNA (bottom panel).
(TIF)
Figure S2 PTB and let-7 co-fractionate in human cells.
Total cell lysate was fractionated through Sephacryl S-300
column. Every second fraction was subjected to RNA and protein
isolation. Let-7 and PTB was monitored with Northern hybridiza-
tion and Western blotting respectively.
(TIF)
Figure S3 miR-21 is associated with PTB. Endogenous
PTB in Hela cells (A), and stably expressed GFP::PTB in U2OS
cells (B) co-purify with miR-21. Experiments were carried out as it
was described at Figure 3. and the Northern hybridizations were
repeated with radioactively labeled probe recognizing miR-21.
(TIF)
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